A Financial Services ETF Buffett Would Like [View article]
Going back to the 2007 peak BRK.a out performed the following of those ETFs mentioned: SPY iyf iyg fxo xlf vfhrfl iat Measured Peak(10/2008) to PEAK (Yesterday), of all of the ETFs listed (SPY IYF IYG FXO XLF VFH) , only SPY is actually profitable - up 4% or so while BRK.A is up almost 30 %. FXO is about even. the others are down. If you were to have bought BRK.a at the 2009 bottom - March 2009, all of the above are up more than the both the SPY and BRK.A. SPY is up 140%) BRK.a - up "only" 125% and once again, FXO is up the most - 250% XLF is up 225% and IYF IYG VFH are up around 200%. based on the comparison service of Yahoo Finance.
6 Superstars For Your Biotech Portfolio: John McCamant [View article]
I presume you are the son of Jim. I used to work with him back in the 70s and 80s and maybe 90s. Say hello for me. SINCE RETIRING IN 06, I have been in a bunch of Med/BIO's past few years. I never stay long enough - tough to hold on in these volatile markets. current holdings include ALNY CNDO ISIS ENZ PCYC GALE SGMO VRTX NKTR I network with another broker Jim knew - he is still an active broker - age 80ish - still shows up at 5:30 am each day except Fridays when he goes fishing. Maybe Jim would like to get together for a beer? I live in Marin, Mt broker buddy works in Napa. Maybe a lunch in Napa would be a fun excuse? Tal best to use email when in this "public domain".
Isis Pharmaceuticals Slides A Little Despite Strong Earnings [View article]
My thoughts - (a) If the forthcoming offering is priced at 19 - a 17% discount from previous high of $22.90 and (b) within pennies ABOVE the current 50 DMAL and ( c) right at the current "consensus Target Price" of all the listed analysts covering the company it appears to have been (coincidentally?) a well thought out strategy of the company and its u/w's in pricing the pending secondary. As mentioned I was stopped out of my last positions at higher levels using trailing stops - but this might be a good opportunity to get back aboard for the next chapter in the life of ISIS (and maybe ALNY). The current high Target Prices (see the attached) of $31/sh (up 12 and 63% from 19) makes for a nice next goal. Especially when the stock will have an additional 10.3 million shares for the bigger "institutional" buyers who want/demand/need greater liquidity to add to their buy list.
An Interesting Alternative To Boring International Dividend ETFs [View article]
Another subject which does not seem to be addressed by Seeking Alpha contributors is the concept of Risk Adjusted TOTAL RETURN which includes both income as well as capital gain distributions. I would suggest that Seeking Alpha might encourage all contributors writing for SA when including performance numbers to assume - for performance measurement purposes - a REINVESTMENT of all income and other distributions. I would also suggest that all contributors provide date as if it were invested in an tax exempt IRA/401k investment portfolio. Obviously significantly different net after tax returns will vary all over the place depending on the tax bracket of investors investing in their taxable accounts and considering qualified vs non qualified income from dividends and "value of tax losses vs capital gain distributions. Also re the above comments about the yields of CVY and LVL, I DO believe that SA should encourage contributors to use a common "definition" of dividend and yield: Some seem to use (A)The total past "trailing" 4 quarters or 12 months of dividend payouts divided by the current price whereas others use (B) the most recent payout and multiply it by 4 or 12 depending on quarterly or monthly distributions. It would be NICE to know which method is being used or compared. It DOES make a difference. Wile I am at it,I also believe that contributors of articles which discuss dividends might provide a measurement of the standard deviation of the past (up to five years) "Rolling 12 months" of dividend payouts and the range between to high and low measurements as well as the most recent.This will help readers understand the extent to which there is a TREND in terms of dividend payouts over the years. Some like "HIGH YIELDS" others emphasize "Growth of dividend payouts" . There is a difference.
The San Francisco Bay Area's Housing Micro-Climates: A Microcosm Of A 2-Speed Recovery [View article]
Any reason you did not include Marin County ? Napa? Sonoma?
My guess would be that each - in the order suggested each has demonstrated a better "risk adjusted" statistic in terms of "Growth" from 2000 to the 07-08 peak in residential home BOUGHT prices for the median priced homes in each county. "Risk" from these peak values to the subsequent low BOUGHT price values in 2009 to 2010 period. "Recovery" values based on current 1Q2013 Bought price values. Duration would be the number of years and quarters between the 2000 Bought Values and The PEAK Bought Values and the Bottom Bought values and the Current 1Q2013 values. Thee stats could be compared with California and other States and or other identifiable cities, counties. Just a thought.
EXCO Resources: Smart Money Believes In This Cheap Stock [View article]
Jaimini: I believe your followers - with an interest in XCO - might be interested in any response you might have regarding Josh Young's comments about the "missing analysis of the breakeven point for XCO's drilling, which is likely higher than the current natural gas price" and any thoughts you have regarding XCO's poor "record in drilling uneconomic gas wells". At least I would. It is hard to believe the 3 sophisticated investors you referenced have not considered such observations - but for whatever reason their Due Diligence researchers have come up with a half full bottle of whisky. Thanks
Consider These 3 Most Punished Silver Stocks [View article]
Compare AGQ with SDLV past three years of bull and bear moves. Obvious leverage works AHQ was up from the 36 month ago level of 27 almost 8 times to 191 from while SLV was up 3 times from 17 to 48. While SLV is back down to 22 while AGQ is back to 24. If one hopes or expects SILVER to recover, I would bet on the AGQ horse to earn the award for best return on the investment.
Open for trading is Credit Suisse's Silver Shares Covered Call ETN (SLVO) with annual fee of 0.65%. The fund is long silver (through the SLV), but forgoes monthly gains in the metal greater than 6%, instead generating income by selling out-of-the-money calls in SLV. [View news story]
I'd like to see the "what if" analysis if one were to employ the same strategy using AGQ instead of SLV
Laying Out My BDC Investment Philosophy [View article]
I hope everyone who reads this report knows that the most accurate and current listing of current positions in BIZD comes from the actual corporate web site:
Silver Hits Costs Of Production: Opportunity For Courageous Investors [View article]
This has been a great forum for both the bulls and bears regarding SILVER. But did I miss any (?) comments regarding the use of AGQ by Silver bulls OR by those who want to hedge their global long equity portfolio rather than SLV or others mentioned. For those who have been "wrong" (or at least premature or early) in the timing of the purchases, Why not take a short or long term loss and use AGQ for a leveraged recovery from what are now relatively discounted values? The charting of the three year ago lows in both SLV (17) and AGQ (27) to their respective 2011 highs provides a nice picture. SLV (at 22) is still up 30% WHILE AGQ(24) is down 11%.
Is these differences in relative values just technical ? or are their fundamental reasons I should not "invest" in AGQ rather than SLV for either hedging OR investment reasons (since it appears that I will get more bang for my bucks).
Checking out the SLV vs the AGQ past three years. SLV was around 17.5 IN MAY OF 2010 SLV was around 48 at it's peak a year later in April-May of 2011 SLV started 2012 out at 25.65 SLV got as high as 36.44 only 2 months later and SLV hit another low at 25.34 in July of 2012 and SLV - Friday hit a low of 25.17 -------------- AGQ had a similar but leveraged pattern started at 27.5 in summer of 2011 - went to a high of 191 in 2011 hit a low of 34.45 (in July of 2012 when SLV hit 25.34) and Friday AGQ is at 31.9 --------------- AGQ is currently 16% above its three year ago price of 27.5 SLV is currently 45% above its three year ago price of 17.5 ----------------------... Based on these stats and your knowledge of the leverage of AGQ and the fact that you would be a buyer of SLV in the 22-24 area. what is your guesstimate as to the price of AGQ if and when SLV gets down to the 22-24 range? -------------- IF I wanted to own Silver as a portfolio or inflation hedge, I believe that AGQ would provide more "silver as a hedge" for the buck than SLV. Would be interested in any thoughts.
Enzo Investors Have To Be In It For The Long Haul [View article]
Your 3/19 comments were timely. Now that the market has significantly revalued the shares almost 40% cheaper than they were only 2-3 months ago, and based on Friday's close and the fact that management will undoubtably be conducting multiple coast "one-on-one" meetings and multiple conference calls with concerned "institutional investors" due to these past few days of "no buyers", it will be interesting to watch the market for signs as to how management has guided sell side analysts toward valuing current price with current and future expectations relating to potential growth in the company business and important longer term product revenue trends.
A Financial Services ETF Buffett Would Like [View article]
Measured Peak(10/2008) to PEAK (Yesterday), of all of the ETFs listed (SPY IYF IYG FXO XLF VFH) , only SPY is actually profitable - up 4% or so while BRK.A is up almost 30 %. FXO is about even. the others are down.
If you were to have bought BRK.a at the 2009 bottom - March 2009,
all of the above are up more than the both the SPY and BRK.A.
SPY is up 140%)
BRK.a - up "only" 125%
and once again, FXO is up the most - 250%
XLF is up 225% and
IYF IYG VFH are up around 200%.
based on the comparison service of Yahoo Finance.
6 Superstars For Your Biotech Portfolio: John McCamant [View article]
I used to work with him back in the 70s and 80s and maybe 90s.
Say hello for me.
SINCE RETIRING IN 06, I have been in a bunch of Med/BIO's past few years.
I never stay long enough - tough to hold on in these volatile markets.
current holdings include
ALNY
CNDO
ISIS
ENZ
PCYC
GALE
SGMO
VRTX
NKTR
I network with another broker Jim knew - he is still an active broker - age 80ish - still shows up at 5:30 am each day except Fridays when he goes fishing.
Maybe Jim would like to get together for a beer?
I live in Marin, Mt broker buddy works in Napa. Maybe a lunch in Napa would be a fun excuse?
Tal
best to use email when in this "public domain".
Isis Pharmaceuticals Slides A Little Despite Strong Earnings [View article]
(a) If the forthcoming offering is priced at 19 - a 17% discount from previous high of $22.90 and
(b) within pennies ABOVE the current 50 DMAL and
( c) right at the current "consensus Target Price" of all the listed analysts covering the company
it appears to have been (coincidentally?) a well thought out strategy of the company and its
u/w's in pricing the pending secondary.
As mentioned I was stopped out of my last positions at higher levels using trailing stops -
but this might be a good opportunity to get back aboard for the next chapter
in the life of ISIS (and maybe ALNY).
The current high Target Prices (see the attached) of $31/sh (up 12 and 63% from 19)
makes for a nice next goal.
Especially when the stock will have an additional 10.3 million shares for the bigger
"institutional" buyers who want/demand/need greater liquidity to add to their buy list.
An Interesting Alternative To Boring International Dividend ETFs [View article]
I would suggest that Seeking Alpha might encourage all contributors writing for SA when including performance numbers to assume - for performance measurement purposes - a REINVESTMENT of all income and other distributions.
I would also suggest that all contributors provide date as if it were invested in an tax exempt IRA/401k investment portfolio.
Obviously significantly different net after tax returns will vary all over the place depending on the tax bracket of investors investing in their taxable accounts and considering qualified vs non qualified income from dividends and "value of tax losses vs capital gain distributions.
Also re the above comments about the yields of CVY and LVL, I DO believe that SA should encourage contributors to use a common "definition" of dividend and yield: Some seem to use
(A)The total past "trailing" 4 quarters or 12 months of dividend payouts divided by the current price
whereas others use
(B) the most recent payout and multiply it by 4 or 12 depending on quarterly or monthly distributions.
It would be NICE to know which method is being used or compared.
It DOES make a difference.
Wile I am at it,I also believe that contributors of articles which discuss dividends might provide a measurement of the standard deviation of the past (up to five years) "Rolling 12 months" of dividend payouts and the range between to high and low measurements as well as the most recent.This will help readers understand the extent to which there is a TREND in terms of dividend payouts over the years. Some like "HIGH YIELDS" others emphasize "Growth of dividend payouts" . There is a difference.
The San Francisco Bay Area's Housing Micro-Climates: A Microcosm Of A 2-Speed Recovery [View article]
My guess would be that each - in the order suggested each has demonstrated a better "risk adjusted" statistic in terms of
"Growth" from 2000 to the 07-08 peak in residential home BOUGHT prices for the median priced homes in each county.
"Risk" from these peak values to the subsequent low BOUGHT price values in 2009 to 2010 period.
"Recovery" values based on current 1Q2013 Bought price values.
Duration would be the number of years and quarters between the 2000 Bought Values and The PEAK Bought Values and the Bottom Bought values and the Current 1Q2013 values.
Thee stats could be compared with California and other States and or other identifiable cities, counties.
Just a thought.
German Blue-Chips Are Increasing Dividend Payouts [View article]
Silver's Support Looking Strong At $22 [View article]
why not AGQ?
EXCO Resources: Smart Money Believes In This Cheap Stock [View article]
At least I would.
It is hard to believe the 3 sophisticated investors you referenced have not considered such observations - but for whatever reason their Due Diligence researchers have come up with a half full bottle of whisky.
Thanks
6 REIT Plays Receiving Plenty Of Investor Attention [View article]
Consider These 3 Most Punished Silver Stocks [View article]
Obvious leverage works
AHQ was up from the 36 month ago level of 27 almost 8 times to 191 from while SLV was up 3 times from 17 to 48.
While SLV is back down to 22 while AGQ is back to 24.
If one hopes or expects SILVER to recover, I would bet on the AGQ horse to earn the award for best return on the investment.
Open for trading is Credit Suisse's Silver Shares Covered Call ETN (SLVO) with annual fee of 0.65%. The fund is long silver (through the SLV), but forgoes monthly gains in the metal greater than 6%, instead generating income by selling out-of-the-money calls in SLV. [View news story]
Laying Out My BDC Investment Philosophy [View article]
http://vaneck.com/BIZD
Based on this information and as of 4/12/12 BIZD holds 26 positions the biggest ten positions representing 68.36% of the total portfolio.
Silver Hits Costs Of Production: Opportunity For Courageous Investors [View article]
But did I miss any (?) comments regarding the use of AGQ by Silver bulls OR by those who want to hedge their global long equity portfolio
rather than SLV or others mentioned.
For those who have been "wrong" (or at least premature or early) in the timing of the purchases, Why not take a short or long term loss and use AGQ for a leveraged recovery from what are now relatively discounted values?
The charting of the three year ago lows in both SLV (17) and AGQ (27) to their respective 2011 highs provides a nice picture.
SLV (at 22) is still up 30% WHILE AGQ(24) is down 11%.
Is these differences in relative values just technical ?
or are their fundamental reasons I should not "invest" in AGQ rather than SLV for either hedging OR investment reasons (since it appears that I will get more bang for my bucks).
Are You A Scared Silver Investor? [View article]
SLV was around 17.5 IN MAY OF 2010
SLV was around 48 at it's peak a year later in April-May of 2011
SLV started 2012 out at 25.65
SLV got as high as 36.44 only 2 months later and
SLV hit another low at 25.34 in July of 2012 and
SLV - Friday hit a low of 25.17
--------------
AGQ had a similar but leveraged pattern
started at 27.5 in summer of 2011
- went to a high of 191 in 2011
hit a low of 34.45 (in July of 2012 when SLV hit 25.34)
and Friday AGQ is at 31.9
---------------
AGQ is currently 16% above its three year ago price of 27.5
SLV is currently 45% above its three year ago price of 17.5
----------------------...
Based on these stats and your knowledge of the leverage of AGQ and the fact that you would be a buyer of SLV in the 22-24 area.
what is your guesstimate as to the price of AGQ if and when SLV
gets down to the 22-24 range?
--------------
IF I wanted to own Silver as a portfolio or inflation hedge, I believe that AGQ would provide more "silver as a hedge" for the buck
than SLV.
Would be interested in any thoughts.
Enzo Investors Have To Be In It For The Long Haul [View article]
Now that the market has significantly revalued the shares almost 40% cheaper than they were only 2-3 months ago, and based on Friday's close and the fact that management will undoubtably be conducting multiple coast "one-on-one" meetings and multiple conference calls with concerned "institutional investors" due to these past few days of "no buyers", it will be interesting to watch the market for signs as to how management has guided sell side analysts toward valuing current price with current and future expectations relating to potential growth in the company business and important longer term product revenue trends.